Standardy hormonalnej terapii zastêpczej po Women’s Health Initiative – przegl¹d najnowszych doniesieñ dotycz¹cych znaczenia drogi podania dla profilu bezpieczeñstwa terapii.

New data and guidelines on menopausal hormone therapy have become available since the publication of the Women's Health Initiative study. This article is aimed to update information regarding the recommendations for the administration route and benefit-risk profile of menopausal hormone therapy. The clinical guidelines generally do not recommend any particular route as better than the others. Available data show that use of transdermal estradiol and micronized progesterone may reduce the risk of venous thromboembolism, breast cancer, stroke, and coronary heart disease. [ABSTRACT FROM AUTHOR]